These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 26010311)

  • 1. A Risk Prediction Index for Advanced Colorectal Neoplasia at Screening Colonoscopy.
    Schroy PC; Wong JB; O'Brien MJ; Chen CA; Griffith JL
    Am J Gastroenterol; 2015 Jul; 110(7):1062-71. PubMed ID: 26010311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A scoring model for predicting advanced colorectal neoplasia in a screened population of asymptomatic Japanese individuals.
    Sekiguchi M; Kakugawa Y; Matsumoto M; Matsuda T
    J Gastroenterol; 2018 Oct; 53(10):1109-1119. PubMed ID: 29359244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Asia-Pacific Colorectal Screening score: a validated tool that stratifies risk for colorectal advanced neoplasia in asymptomatic Asian subjects.
    Yeoh KG; Ho KY; Chiu HM; Zhu F; Ching JY; Wu DC; Matsuda T; Byeon JS; Lee SK; Goh KL; Sollano J; Rerknimitr R; Leong R; Tsoi K; Lin JT; Sung JJ;
    Gut; 2011 Sep; 60(9):1236-41. PubMed ID: 21402615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Derivation and Validation of a Scoring System to Stratify Risk for Advanced Colorectal Neoplasia in Asymptomatic Adults: A Cross-sectional Study.
    Imperiale TF; Monahan PO; Stump TE; Glowinski EA; Ransohoff DF
    Ann Intern Med; 2015 Sep; 163(5):339-46. PubMed ID: 26259154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combining risk factors with faecal immunochemical test outcome for selecting CRC screenees for colonoscopy.
    Stegeman I; de Wijkerslooth TR; Stoop EM; van Leerdam ME; Dekker E; van Ballegooijen M; Kuipers EJ; Fockens P; Kraaijenhagen RA; Bossuyt PM
    Gut; 2014 Mar; 63(3):466-71. PubMed ID: 23964098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of advanced colorectal neoplasia for colorectal cancer screening.
    Wong MC; Lam TY; Tsoi KK; Chan VC; Hirai HW; Ching JY; Sung JJ
    Am J Prev Med; 2014 May; 46(5):433-9. PubMed ID: 24745632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a clinical risk index for advanced colorectal neoplasia among a North American population of screening age.
    Ruco A; Stock D; Hilsden RJ; McGregor SE; Paszat LF; Saskin R; Rabeneck L
    BMC Gastroenterol; 2015 Nov; 15():162. PubMed ID: 26585867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A validated tool to predict colorectal neoplasia and inform screening choice for asymptomatic subjects.
    Wong MC; Lam TY; Tsoi KK; Hirai HW; Chan VC; Ching JY; Chan FK; Sung JJ
    Gut; 2014 Jul; 63(7):1130-6. PubMed ID: 24045331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk stratification for advanced colorectal neoplasia according to fecal hemoglobin concentration in a colorectal cancer screening program.
    Auge JM; Pellise M; Escudero JM; Hernandez C; Andreu M; Grau J; Buron A; López-Cerón M; Bessa X; Serradesanferm A; Piracés M; Macià F; Guayta R; Filella X; Molina R; Jimenez W; Castells A;
    Gastroenterology; 2014 Sep; 147(3):628-636.e1. PubMed ID: 24937264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Stratification and Shared Decision Making for Colorectal Cancer Screening: A Randomized Controlled Trial.
    Schroy PC; Duhovic E; Chen CA; Heeren TC; Lopez W; Apodaca DL; Wong JB
    Med Decis Making; 2016 May; 36(4):526-35. PubMed ID: 26785715
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Stratification Score Improves Sensitivity for Advanced Colorectal Neoplasia in Colorectal Cancer Screening: The Oshima Study Workgroup.
    Sekiguchi M; Kakugawa Y; Ikematsu H; Hotta K; Konda K; Tanaka Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Imai K; Ito S; Koga Y; Iwasaki M; Murakami Y; Matsuda T
    Clin Transl Gastroenterol; 2021 Mar; 12(3):e00319. PubMed ID: 33939384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of clinical risk stratification and fecal immunochemical test results to prioritize colonoscopy screening in asymptomatic participants.
    Aniwan S; Rerknimitr R; Kongkam P; Wisedopas N; Ponuthai Y; Chaithongrat S; Kullavanijaya P
    Gastrointest Endosc; 2015 Mar; 81(3):719-27. PubMed ID: 25708760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a risk stratification-based screening model for predicting colorectal advanced neoplasia in Korea.
    Kim DH; Cha JM; Shin HP; Joo KR; Lee JI; Park DI
    J Clin Gastroenterol; 2015 Jan; 49(1):41-9. PubMed ID: 24583751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of Colorectal Neoplasia in Individuals With Self-Reported Family History: A Prospective Colonoscopy Study from 16 Asia-Pacific Regions.
    Wong MC; Ching JY; Chiu HM; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Ng SC; Wu JC; Chan FK; Sung JJ
    Am J Gastroenterol; 2016 Nov; 111(11):1621-1629. PubMed ID: 26977757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorectal cancer screening mode preferences among US veterans.
    Powell AA; Burgess DJ; Vernon SW; Griffin JM; Grill JP; Noorbaloochi S; Partin MR
    Prev Med; 2009 Nov; 49(5):442-8. PubMed ID: 19747502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a scoring system to identify individuals at high risk for advanced colorectal neoplasms who should undergo colonoscopy screening.
    Tao S; Hoffmeister M; Brenner H
    Clin Gastroenterol Hepatol; 2014 Mar; 12(3):478-85. PubMed ID: 24022090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A modified colorectal screening score for prediction of advanced neoplasia: A prospective study of 5744 subjects.
    Sung JJY; Wong MCS; Lam TYT; Tsoi KKF; Chan VCW; Cheung W; Ching JYL
    J Gastroenterol Hepatol; 2018 Jan; 33(1):187-194. PubMed ID: 28561279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of serrated lesions, risk factors, and their association with synchronous advanced colorectal neoplasia in asymptomatic screened individuals.
    Sekiguchi M; Kakugawa Y; Matsumoto M; Nakamura K; Mizuguchi Y; Takamaru H; Yamada M; Sakamoto T; Saito Y; Matsuda T
    J Gastroenterol Hepatol; 2020 Nov; 35(11):1938-1944. PubMed ID: 32441416
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Risk-Scoring System Combined With a Fecal Immunochemical Test Is Effective in Screening High-Risk Subjects for Early Colonoscopy to Detect Advanced Colorectal Neoplasms.
    Chiu HM; Ching JY; Wu KC; Rerknimitr R; Li J; Wu DC; Goh KL; Matsuda T; Kim HS; Leong R; Yeoh KG; Chong VH; Sollano JD; Ahmed F; Menon J; Sung JJ;
    Gastroenterology; 2016 Mar; 150(3):617-625.e3. PubMed ID: 26627608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting advanced neoplasia at colonoscopy in a diverse population with the National Cancer Institute colorectal cancer risk-assessment tool.
    Ladabaum U; Patel A; Mannalithara A; Sundaram V; Mitani A; Desai M
    Cancer; 2016 Sep; 122(17):2663-70. PubMed ID: 27219715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.